Ticker
CTSOCompany Name
CYTOSORBENTS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 9.18M | 26.81% | $ 34.26M |
3/31/2025 | $ 9.77M | 28.3% | $ 34.54M |
12/31/2024 | $ 10.47M | 29.41% | $ 35.59M |
9/30/2024 | $ 14.07M | 37.29% | $ 37.74M |
6/30/2024 | $ 13.17M | 35.44% | $ 37.16M |
3/31/2024 | $ 13.18M | 35.92% | $ 36.69M |
12/31/2023 | $ 13.96M | 38.4% | $ 36.35M |
9/30/2023 | $ 14.23M | 38.4% | $ 37.07M |
6/30/2023 | $ 15.52M | 42.68% | $ 36.37M |
3/31/2023 | $ 15.67M | 44.21% | $ 35.45M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for CYTOSORBENTS CORP is calculated as follows: COGS [ $ 10.62M ] / Revenues [ $ 36.48M ]
(=) COGS % [ 29.11% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.81K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.91% |
median | 50.54% |
std | 31.59% |